Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (1395)	3/3/2000 11:41:00 AM
From: Larry Meneely	Read Replies (1) \| Respond to of 2344

Whew! Institution or institutions bought 50,000 X US$20 = $1,000,000 this morning. Could account for the spike. Look here for more information: thomsoninvest.net Larry Meneely

To: Pseudo Biologist who wrote (1395)	3/3/2000 11:53:00 AM
From: RWReeves	Read Replies (1) \| Respond to of 2344

Welll PB I know how you feel about CLTR, so I can understand this POV. Besides, with all your newfound wealth you can afford to buy one of these outright, can't you? Maybe another shrine at least <g>. I'll post the IMMU pipeline as I understand it over on the IMMU thread and see if you disagree with it. Not long either of these anymore, but have been until recently. Plus, uh, this will no doubt attract flambe' but sadly, Canadian biotech companies have not historically attracted the same multiples for science as US firms. QLTI may be changing that but slowly. BTW I own a fair amount of various Canadian bios so not dissing, just bemoaning. RWR